✦ LIBER ✦

Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation

✍ Scribed by Navin Wadehra; Sherif Farag; Brian Bolwell; Patrick Elder; Sam Penza; Matt Kalaycio; Belinda Avalos; Brad Pohlman; Guido Marcucci; Ronald Sobecks; Thomas Lin; Steven Andrèsen; Edward Copelan

Book ID: 116279114
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 180 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.08.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term Outcome of Hodgkin Disease Pat

Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation—A Similar Experience

✍ Eric C. Santos; Jolynn Sessions; Don Hutcherson; Christopher Flowers; Amelia Lan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 76 KB

High-dose melphalan versus busulfan, cyc

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Pharmacokinetic-Directed High-Dose Busul

Pharmacokinetic-Directed High-Dose Busulfan Combined with Cyclophosphamide and Etoposide Results in Predictable Drug Levels and Durable Long-Term Survival in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

✍ Zhang, Hongzheng; Graiser, Michael; Hutcherson, Donald A.; Dada, M. Olufemi; McM 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Double high-dose therapy for Hodgkin’s d

Double high-dose therapy for Hodgkin’s disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation

✍ Stewart, D A; Guo, D; Glück, S; Morris, D; Chaudhry, A; deMetz, C; Klassen, J; B 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 65 KB

Long-term outcome of high-dose melphalan

Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis

✍ Perz, J B; Rahemtulla, A; Giles, C; Szydlo, R M; Davis, J; Gopaul, D; Gillmore, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

Improved Outcomes in Intermediate- and H

Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen

✍ Charu Aggarwal; Sameer Gupta; William P. Vaughan; Gene B. Saylors; Donna E. Salz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 170 KB